Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fibrillary glomerulopathy]

A Kovác1, I Slugen, D Danis

  • 1Katedra vnútorného lekárstva Institútu pre vzdelávanie pracovníkov v zdravotníctve, Bratislava.

Vnitrni Lekarstvi
|May 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transforming post-STEMI care: The IMPACS study design and baseline patient profile.

International journal of cardiology·2026
Same author

Prophylaxis and treatment of postoperative nausea and vomiting.

BJA education·2026
Same author

Treatment outcome of NSCLC patients with BRAF<sup>non-V600E</sup> mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany.

ESMO open·2025
Same author

Ultrasound detection of non-atherosclerotic intima-medial abnormalities of lower limbs arteries in amateur endurance runners.

Journal of ultrasound·2024
Same author

Dexmedetomidine vs. propofol sedation reduces the duration of mechanical ventilation after cardiac surgery - a randomized controlled trial.

European review for medical and pharmacological sciences·2023
Same author

The presence of pyruvate carboxylase in the human brain and its role in the survival of cultured human astrocytes.

Physiological research·2023
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Fibrillar glomerulopathies, characterized by microfibrils in kidney glomeruli, are classified into amyloid and non-amyloid types. Accurate differential diagnosis is crucial, especially for immunoglobulin-positive cases linked to severe systemic diseases.

Area of Science:

  • Nephrology
  • Pathology
  • Immunology

Context:

  • Fibrillar glomerulopathies involve extracellular microfibrils and microtubules in kidney glomeruli (8-60 nm diameter).
  • These conditions are broadly categorized into amyloid and non-amyloid types.
  • Further classification is based on immunofluorescence findings: immunoglobulin-positive and immunoglobulin-negative.

Purpose:

  • To review current knowledge on the diagnosis and differential diagnosis of fibrillar glomerulopathies.
  • To highlight the importance of distinguishing between different types of fibrillar glomerulopathies.
  • To emphasize the clinical significance of immunoglobulin-positive fibrillar glomerulopathies.

Summary:

  • Fibrillar glomerulopathies are defined by the presence of microfibrils and microtubules within the glomerular structures of the kidney.

Related Experiment Videos

  • Diagnosis involves differentiating between amyloid and non-amyloid forms, and further classifying them based on immunoglobulin staining via immunofluorescence.
  • Immunoglobulin-positive cases require careful differential diagnosis due to their association with severe conditions like cryoglobulinemia, monoclonal gammopathies, systemic lupus erythematosus, and immunotactoid glomerulopathy.

    • Impact:

    • Improved diagnostic accuracy for fibrillar glomerulopathies.
    • Enhanced understanding of the clinical implications of immunoglobulin-positive variants.
    • Facilitation of timely and appropriate management for patients with associated systemic diseases.